Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
28.63 USD26.76 USD33.55 USD
+206%
26.76 USDCurrent price is 205.9% above the base model value.
E
HealthcareMedical DevicesUnited States
EW.US · Edwards Lifesciences Corporation
NYQ · US · USD
Latest price81.86 USD
30D+7.62%
Vs. base value+205%
Research summary
EW.US latest organized financial period shows revenue grew +11.55% YoY and net income declined -74.28% YoY. Current price is about 81.86 USD, while the model base case is about 26.85 USD; the current price sits +205% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue6B USD
Net income1B USD
Free cash flow1B USD
Operating cash flow2B USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:27
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price81.86 USD
Base value26.85 USD
Vs. base+205%
Price date2026/04/28
27.79 USD26.85 USD30.24 USD
+205%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
47.54 USD44.44 USD55.72 USD
+84.2%
44.44 USDCurrent price is 84.2% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth12.7%
Current price implies roughly 12.7% annualized FCF growth.
12.7%Current price implies roughly 12.7% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
22.96 USD22.96 USD22.96 USD
+257%
22.96 USDCurrent price is 256.6% above the base model value.
Updated: 2026/04/29 07:27
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 9
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | 6B USD | 1B USD | 1B USD | 1.83 |
| 2024/12/30 | Annual | 5B USD | 4B USD | 260M USD | 6.97 |
| 2023/12/30 | Annual | 5B USD | 1B USD | 630M USD | 2.3 |
| 2022/12/30 | Annual | 4B USD | 2B USD | 953M USD | 2.44 |
| 2021/12/30 | Annual | - | - | - | - |
Ad placement